Nuheara IQBuds Max vs Signia Pure C&G IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Nuheara IQBuds Max
The Nuheara IQBuds Max is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.4/5 in our lab testing. At $499, it sits in the affordable tier of the OTC category, ranking #46 of 65 devices tested. The standout performance area for the IQBuds Max is music streaming, which scores a strong 4.3/5—significantly above the category average by 2.38 points. This makes it one of the better choices in the OTC space for users who prioritize audio entertainment alongside hearing assistance. However, speech performance presents a mixed picture: speech in quiet scores 2.0/5, falling 0.78 points below the category average, while speech in noise scores a low 1.5/5, though this is essentially at the category average. Own-voice comfort is mixed at 2.2/5, sitting slightly below the category average. Feedback handling scores a solid 3.4/5 in absolute terms, though this is 1.14 points below the category average of 4.54/5. The device features rechargeable batteries and supports both iPhone and Android streaming with hands-free capability. The IQBuds Max is best suited for users who want an affordable entry into amplification with strong music streaming performance, but who have modest expectations for speech clarity improvement. Those prioritizing speech understanding may want to consider higher-ranked alternatives in the same price range, such as the Elehear Beyond or Apple AirPods Pro 2.
Choice

Signia Pure C&G IX
The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit